These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30026621)

  • 1. Long-term clinical control of feline pancreatic carcinoma with toceranib phosphate.
    Dedeaux AM; Langohr IM; Boudreaux BB
    Can Vet J; 2018 Jul; 59(7):751-754. PubMed ID: 30026621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
    Olmsted GA; Farrelly J; Post GS; Smith J
    J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline exocrine pancreatic carcinoma: a retrospective study of 34 cases.
    Linderman MJ; Brodsky EM; de Lorimier LP; Clifford CA; Post GS
    Vet Comp Oncol; 2013 Sep; 11(3):208-18. PubMed ID: 22612638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and response in cats with neoplasia treated with toceranib phosphate.
    Harper A; Blackwood L
    J Feline Med Surg; 2017 Jun; 19(6):619-623. PubMed ID: 27090289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of toceranib phosphate (Palladia) use in the treatment of feline pancreatic carcinoma.
    Rosario CO; Musser ML; Yuan L; Mochel JP; Talbott J; Johannes CM; Berger EP
    Can Vet J; 2023 Dec; 64(12):1143-1148. PubMed ID: 38046430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of toceranib phosphate (Palladia®) toxicity in cats.
    Merrick CH; Pierro J; Schleis SE; Sones EA; Wright ZM; Regan RC; Siedlecki CT; Bergman PJ
    Vet Comp Oncol; 2017 Sep; 15(3):710-717. PubMed ID: 27041701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of toceranib phosphate (Palladia) use in cats with mast cell neoplasia.
    Berger EP; Johannes CM; Post GS; Rothchild G; Shiu KB; Wetzel S; Fox LE
    J Feline Med Surg; 2018 Feb; 20(2):95-102. PubMed ID: 29172873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of toceranib phosphate in cats with macroscopic mammary adenocarcinoma.
    Del Portillo Miguel I; Blackwood L; Maiques E; Pérez Roger I; Poch Jiménez E; Borrego J
    J Feline Med Surg; 2024 Aug; 26(8):1098612X241256473. PubMed ID: 39212426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
    Musser ML; Johannes CM
    BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Survival and Glycemic Control with Toceranib Phosphate and Prednisone for a Metastatic Canine Insulinoma.
    Flesner BK; Fletcher JM; Smithee T; Boudreaux B
    J Am Anim Hosp Assoc; 2019; 55(1):e55105. PubMed ID: 30427714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma.
    Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N
    J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report.
    Fuertes-Recuero M; Vázquez-Fernández E; Lizasoain-Sánz G; Arroba-Alonso A; Sánchez-López A; Martínez-de-Merlo E; Suárez-Redondo M; Ortiz-Diez G
    Vet Res Commun; 2024 Jun; 48(3):1921-1927. PubMed ID: 38453822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
    Holtermann N; Kiupel M; Hirschberger J
    Vet Comp Oncol; 2017 Jun; 15(2):632-640. PubMed ID: 26762970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and trends of proteinuria, azotemia and hypertension in cats receiving toceranib phosphate.
    Williams K; MacDonald-Dickinson V; Matsuyama A
    J Feline Med Surg; 2024 Sep; 26(9):1098612X241266418. PubMed ID: 39287178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of feline mast cell tumour with intertumoral heterogeneity: Identification of secondary mutations c.998G>C and c.2383G>C in KIT after resistance to toceranib.
    Tani H; Hifumi T; Ito K; Kuramoto T; Miyoshi N; Fujiki M; Nakayama T
    Vet Med Sci; 2024 Sep; 10(5):e70003. PubMed ID: 39177283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined surgical and medical management of a cat with gastrinoma.
    Myers-Nodes J; Mazepa ASW
    J Small Anim Pract; 2022 Aug; 63(8):632-634. PubMed ID: 35067928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toceranib phosphate-associated nephrotic syndrome in a dog: a case report.
    Remerowski SM; Herrera CL; Donnelly LL
    BMC Vet Res; 2021 Apr; 17(1):146. PubMed ID: 33827545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial pancreatectomy and splenectomy using a bipolar vessel sealing device in a cat with an anaplastic pancreatic carcinoma.
    Knell S; Venzin C
    Schweiz Arch Tierheilkd; 2012 Jul; 154(7):298-301. PubMed ID: 22753253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of a feline gastric stromal cell tumour with toceranib phosphate: a case study.
    McGregor O; Moore AS; Yeomans S
    Aust Vet J; 2020 May; 98(5):181-184. PubMed ID: 31971262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma.
    Hicks KA; Leeper HJ; Curran KM
    Vet Comp Oncol; 2024 Jun; 22(2):245-254. PubMed ID: 38622074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.